Treated mixed matrix polymeric membranes

Patent metadata

Field	Value
Publication number	US-2016263533-A1
Application number	US-201415031871-A
Country	US
Kind code	A1
Filing date	Dec 15, 2014
Priority date	Dec 16, 2013
Publication date	Sep 15, 2016
Grant date	—

Abstract

Disclosed are treated mixed matrix polymeric membranes comprising a plurality of metal-organic frameworks (MOFs) and a polymeric matrix, wherein the plurality of MOFs are attached to the polymeric matrix through covalent or hydrogen bonds or Van der Waals interaction. The membranes can be treated with plasma, electromagnetic radiation, or thermal energy or any combination thereof

First claim

1 . A treated mixed matrix polymeric membrane comprising a polymeric matrix and a plurality of at least a first metal-organic framework (MOF), wherein the plurality of the first MOFs are attached to the polymeric matrix through covalent bonds formed between a functional group from the MOFs and a reactive group from the polymers of the polymeric matrix, wherein the polymeric matrix comprises a polyimide polymer, a polyetherimide polymer, a polymer of intrinsic microporosity (PIM), or a blend of at least two of said polymers, and wherein the polymeric membrane has been plasma-treated, treated with electromagnetic radiation, or thermally-treated.

2 . (canceled)

3 . The treated mixed matrix polymeric membrane of claim 1 , wherein the plurality of the first MOFs are zeolitic imidazolate frameworks (ZIFs) and wherein the functional group is on an imidazolate ligand of the first ZIFs.

4 . The treated mixed matrix polymeric membrane of claim 3 , wherein the imidazolate ligand is an imidazole carboxyaldehyde ligand that has been functionalized with an amino group or an imine group.

5 . The treated mixed matrix polymeric membrane of claim 3 , wherein the functional group is an amino group or an imine group.

6 . The treated mixed matrix polymeric membrane of claim 3 , wherein each of the first ZIFs comprises (1) an imidazole carboxyaldehyde ligand that has been functionalized with an amino group and (2) a methyl imidazole ligand.

7 . The treated mixed matrix polymeric membrane of claim 6 , wherein 1 to 99% of the imidazolate ligands of the first ZIFs are functionalized with a functional group.

8 . The treated mixed matrix polymeric membrane of claim 3 , wherein the plurality of first ZIFs are ZIF-8-90 or ZIF-8-90-EDA.

9 . The treated mixed matrix polymeric membrane of claim 8 , further comprising a plurality of at least a second ZIF that is different from the plurality of the first ZIFs.

10 . The treated mixed matrix polymeric membrane of claim 9 , wherein the plurality of first ZIFs is ZIF-8-90 and the plurality of second ZIFs is ZIF-8-90-EDA.

11 . The treated mixed matrix polymeric membrane of claim 1 , wherein the plurality of first MOFs is isoreticular metal-organic framework-3 (IRMOF-3).

12 . The treated mixed matrix polymeric membrane of claim 11 , further comprising a plurality of at least a second MOF that is different from the first MOF.

13 - 15 . (canceled)

16 . The treated mixed matrix polymeric membrane of claim 1 , wherein the first MOFs have a pore size between about 0.1 and 5 nm.

17 . The treated mixed matrix polymeric membrane of claim 1 , wherein the mixed matrix polymeric membrane comprises 5 to 90 mole percent of MOFs.

18 - 38 . (canceled)

39 . A method for separating at least one component from a mixture of components, the process comprising: contacting a mixture of components on a first side of the treated mixed matrix polymeric membrane of claim 1 , such that at least a first component is retained on the first side in the form of a retentate and at least a second component is permeated through the membrane to a second side in the form of a permeate.

40 . The method of claim 39 , wherein the first component is a first gas and the second component is a second gas.

41 . The method of claim 40 , wherein the first gas is hydrogen and the second gas is nitrogen, or the first gas is hydrogen and the second gas is methane, or the first gas is carbon dioxide and the second gas is methane.

42 - 45 . (canceled)

46 . A method of preparing the treated mixed matrix polymeric membrane of claim 1 comprising:
(a) obtaining a plurality of at least the first MOFs comprising at least one functional group;
(b) attaching the plurality of the first MOFs to a polymer or a polymer blend through covalent bonds formed between the matrix and the functional group of the MOFs;
(c) forming a polymeric membrane comprising a polymeric matrix with the polymer or polymeric blend from step (b); and
(d) subjecting at least a portion of the surface of the formed polymeric membrane to plasma, electromagnetic radiation, or thermal treatment, or any combination thereof.

47 . (canceled)

48 . The method of claim 46 , wherein the membrane is subjected to plasma gas comprising a reactive species for 30 seconds to 30 minutes, 30 second to 10 minutes, 1 to 5 minutes, or 2 to 4 minutes.

49 . (canceled)

50 . (canceled)

51 . The method of claim 48 , wherein the reactive gas comprises O 2 and CF 4 at a ratio of up to 1:2.

52 - 54 . (canceled)

55 . The method of claim 46 , wherein at least a portion of the surface of the formed polymeric membrane is subjected to a combination of at least two of plasma, electromagnetic radiation, or thermal treatment, and wherein said treatments are sequential or overlap one another.

56 - 59 . (canceled)

Assignees

• Sabic Global Technologies Bv

Inventors

• Odeh Ihab N
• Shao Lei
• Liu Yunyang

Classifications

• B01D2323/35

  Use of magnetic or electrical fields · CPC title

• B01D53/228

  characterised by specific membranes · CPC title

• B01D71/72

  Macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, not provided for in a single one of the groups B01D71/46 - B01D71/70 {and B01D71/701 - B01D71/702} · CPC title

• B01D2323/34

  Use of radiation · CPC title

• B01D69/148 Primary

  Organic/inorganic mixed matrix membranes · CPC title